Pacira BioSciences (PCRX) Tax Rate (2013 - 2026)

Pacira BioSciences' Tax Rate history runs 14 years deep, the most recent figure standing at 41.66% for Q1 2026.

• On a quarterly basis, Tax Rate fell 307.0% year-over-year to 41.66% in Q1 2026; TTM through Mar 2026 was 60.98%, a 11343.0% increase from a year earlier, with the FY2025 full-year figure at 58.31%, up 11608.0% from the prior year.
• Tax Rate advanced to 41.66% in Q1 2026 per PCRX's latest filing, from 186.69% in the prior quarter.
• Across five years, Tax Rate topped out at 133.49% in Q3 2022 and bottomed at 186.69% in Q4 2025.
• The 5-year median for Tax Rate is 34.17% (2024), against an average of 12.95%.
• Across the five-year window, Tax Rate soared 10638 bps in 2022 and tumbled 22385 bps in 2025, its largest moves.
• Year by year, Tax Rate stood at 44.09% in 2022, then sank by 40 bps to 26.25% in 2023, then surged by 42 bps to 37.16% in 2024, then tumbled by 602 bps to 186.69% in 2025, then surged by 122 bps to 41.66% in 2026.
• Per Business Quant, the three latest PCRX Tax Rate figures stand at 41.66% (Q1 2026), 186.69% (Q4 2025), and 42.97% (Q3 2025).